Tilman Sauerbruch
Overview
Explore the profile of Tilman Sauerbruch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
270
Citations
5003
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Schierwagen R, Dietrich P, Klein S, Uschner F, Ortiz C, Tyc O, et al.
Proc Natl Acad Sci U S A
. 2020 Nov;
117(44):27082-27084.
PMID: 33144522
No abstract available.
12.
Uschner F, Gluckert K, Paternostro R, Gnad T, Schierwagen R, Mandorfer M, et al.
Liver Int
. 2020 Jul;
40(9):2228-2241.
PMID: 32627946
Background & Aims: Phosphodiesterase-5 inhibitors (PDE-5-I) are used for treatment of erectile dysfunction (ED), which is common in patients with cirrhosis. They may improve portal hypertension (PH), but contradictory data...
13.
Cremonese C, Schierwagen R, Uschner F, Torres S, Tyc O, Ortiz C, et al.
Int J Mol Sci
. 2020 May;
21(9).
PMID: 32392802
Non-alcoholic fatty liver disease (NAFLD) is gaining in importance and is linked to obesity. Especially, the development of fibrosis and portal hypertension in NAFLD patients requires treatment. Transgenic TGR(mREN2)27 rats...
14.
Sauerbruch T, Satzinger G
Dtsch Med Wochenschr
. 2019 Dec;
144(25):1818-1824.
PMID: 31847020
On August 26 in 1753, Balthasar Neumann's wife wrote a letter to the Abbot of Neresheim describing her husband's disease one week after his death. This article outlines Neumann's medical...
15.
Klein S, Kleine C, Pieper A, Granzow M, Gautsch S, Himmit M, et al.
Sci Rep
. 2019 Aug;
9(1):11598.
PMID: 31406138
Prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing. Resulting fibrosis and portal hypertension, as a possible secondary event, may necessitate treatment. Overexpression of mouse renin in the transgenic rat...
16.
Trebicka J, Amoros A, Pitarch C, Titos E, Alcaraz-Quiles J, Schierwagen R, et al.
Front Immunol
. 2019 Apr;
10:476.
PMID: 30941129
Patients with acutely decompensated cirrhosis (AD) may or may not develop acute-on-chronic liver failure (ACLF). ACLF is characterized by high-grade systemic inflammation, organ failures (OF) and high short-term mortality. Although...
17.
Trebicka J, Bastgen D, Byrtus J, Praktiknjo M, Terstiegen S, Meyer C, et al.
Clin Gastroenterol Hepatol
. 2019 Apr;
17(13):2793-2799.e1.
PMID: 30940552
Background & Aims: We studied the effects of diameter of covered, self-expandable, nitinol stents on survival times of patients with a transjugular intrahepatic portosystemic shunt (TIPS). Methods: We collected data...
18.
Sauerbruch T, Wong F
Digestion
. 2018 Sep;
99(4):261-266.
PMID: 30212817
Background: The development of cirrhosis with resultant portal hypertension can lead to oesophageal varices at a rate of 7% per annum. Bleeding from varices happens when the portal pressure is...
19.
Kleber G, Sauerbruch T
Gastroenterology
. 2018 Aug;
155(5):1648-1649.
PMID: 30142338
No abstract available.
20.
Sauerbruch T, Schierwagen R, Trebicka J
F1000Res
. 2018 May;
7.
PMID: 29780579
Portal hypertension is one cause and a part of a dynamic process triggered by chronic liver disease, mostly induced by alcohol or incorrect nutrition and less often by viral infections...